{"meta":{"query_hash":"83beab76edba","filters":{"venue":"Advances in Cell and Gene Therapy"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/83beab76edba","api":"https://metacan.xera.ac/api/v1/cohort?venue=Advances+in+Cell+and+Gene+Therapy"},"results":[{"id":"W2902960154","doi":"10.1002/acg2.29","title":"Advances in ex vivo T cell depletion - where do we stand?","year":2018,"lang":"en","type":"article","venue":"Advances in Cell and Gene Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Ottawa Hospital; National Institutes of Health; Ottawa Hospital Research Institute","keywords":"Medicine; Calcineurin; Myeloid leukemia; CD34; Hematopoietic stem cell transplantation; Methotrexate; Oncology; Ex vivo; Transplantation; Immunology; Internal medicine; Stem cell; In vivo; Biology","score_opus":0.01087792535393666,"score_gpt":0.28404661068210296,"score_spread":0.2731686853281663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902960154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005813934,0.9861098,0.0015502892,0.008148181,0.0012786813,0.000015021218,0.00006746806,0.0000339208,0.0022152888],"genre_scores_gemma":[0.00352985,0.98647785,0.0025202075,0.0048529147,0.001437801,0.000034927452,0.00010339626,0.000016666112,0.0010263592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916816,0.0003300317,0.000099533994,0.00012198638,0.0002097317,0.00007050032],"domain_scores_gemma":[0.99685705,0.0018697547,0.00025679785,0.00011088357,0.0006953278,0.00021019661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047995565,0.00064419495,0.0012266436,0.0007694891,0.00028735364,0.0024411888,0.00090293045,0.0014123854,0.0037609302],"category_scores_gemma":[0.0034387102,0.00021287112,0.000654729,0.0007875691,0.0008192046,0.003741917,0.0009763635,0.003785623,0.0021415295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003175309,0.00013885795,0.00058751577,0.009702172,0.000101639984,0.00010861266,0.00010607945,0.00039311714,0.0032646146,0.013355299,0.027609648,0.9443149],"study_design_scores_gemma":[0.00007245284,0.0006954945,0.00089080114,0.004908742,0.00025998947,0.00049847545,0.00017219804,0.0002300262,0.0026007416,0.0133972615,0.97624004,0.00003386211],"about_ca_topic_score_codex":0.00050521357,"about_ca_topic_score_gemma":0.0010226755,"teacher_disagreement_score":0.0047995565,"about_ca_system_score_codex":0.00071001984,"about_ca_system_score_gemma":0.001857074,"threshold_uncertainty_score":0.025382817},"labels":[],"label_agreement":null}]}